Sarah Kattakuzhy

1.1k total citations
45 papers, 664 citations indexed

About

Sarah Kattakuzhy is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah Kattakuzhy has authored 45 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 26 papers in Hepatology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah Kattakuzhy's work include Hepatitis C virus research (26 papers), HIV, Drug Use, Sexual Risk (15 papers) and Opioid Use Disorder Treatment (13 papers). Sarah Kattakuzhy is often cited by papers focused on Hepatitis C virus research (26 papers), HIV, Drug Use, Sexual Risk (15 papers) and Opioid Use Disorder Treatment (13 papers). Sarah Kattakuzhy collaborates with scholars based in United States, Nigeria and Rwanda. Sarah Kattakuzhy's co-authors include Elana Rosenthal, Shyam Kottilil, Colleen Hadigan, Rachel Silk, Eleanor Wilson, Chloe Gross, Henry Masur, Lydia Tang, Elizabeth Akoth and Angie Price and has published in prestigious journals such as Annals of Internal Medicine, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

Sarah Kattakuzhy

38 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Kattakuzhy United States 13 489 424 139 124 64 45 664
Deepak Suri United Kingdom 9 525 1.1× 438 1.0× 48 0.3× 63 0.5× 98 1.5× 14 810
Milan Khara Canada 9 346 0.7× 245 0.6× 88 0.6× 84 0.7× 13 0.2× 26 509
Philip Bruggmann Switzerland 18 1.0k 2.1× 1.0k 2.4× 237 1.7× 48 0.4× 12 0.2× 73 1.2k
Marianne Jauncey Australia 16 598 1.2× 238 0.6× 103 0.7× 405 3.3× 78 1.2× 43 795
Katelyn J Cullen United Kingdom 8 254 0.5× 185 0.4× 64 0.5× 56 0.5× 15 0.2× 13 319
Maryam Alavi Australia 22 1.0k 2.1× 971 2.3× 155 1.1× 67 0.5× 7 0.1× 65 1.2k
Alya Briceño United States 10 427 0.9× 195 0.5× 191 1.4× 125 1.0× 11 0.2× 15 512
Håvard Midgard Norway 12 594 1.2× 623 1.5× 132 0.9× 33 0.3× 6 0.1× 28 689
Amira Mohsen Egypt 14 234 0.5× 129 0.3× 89 0.6× 89 0.7× 5 0.1× 49 535
Eduardo Martínez Spain 11 136 0.3× 39 0.1× 194 1.4× 32 0.3× 73 1.1× 28 422

Countries citing papers authored by Sarah Kattakuzhy

Since Specialization
Citations

This map shows the geographic impact of Sarah Kattakuzhy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Kattakuzhy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Kattakuzhy more than expected).

Fields of papers citing papers by Sarah Kattakuzhy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Kattakuzhy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Kattakuzhy. The network helps show where Sarah Kattakuzhy may publish in the future.

Co-authorship network of co-authors of Sarah Kattakuzhy

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Kattakuzhy. A scholar is included among the top collaborators of Sarah Kattakuzhy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Kattakuzhy. Sarah Kattakuzhy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carpenter, Joseph, Sarah Kattakuzhy, Alaina Steck, et al.. (2025). P-1422. Low Use of Oral Antibiotics for People Hospitalized with Serious Injection-Related Infections: the CHOICE+ Cohort. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Atkinson, Gordon, et al.. (2025). “Stigma is our most powerful enemy”: Understanding opioid use disorder stigma and the role of peer support in rural Maryland. International Journal of Drug Policy. 143. 104924–104924.
3.
Traver, Edward C, Ayako Fujita, Becky Reece, et al.. (2025). P-1418. Risk for Early and Late Readmission for Serious Injection-Related Infections: the CHOICE+ Cohort. Open Forum Infectious Diseases. 12(Supplement_1).
4.
Harfouch, Omar, Andrea Lisco, Ashley Davis, et al.. (2024). High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth. Open Forum Infectious Diseases. 11(12). ofae662–ofae662. 2 indexed citations
5.
Carpenter, Joseph, Timothy P. Moran, Hana Akselrod, et al.. (2023). Use of nonstigmatizing language is associated with improved outcomes in hospitalized people who inject drugs. Journal of Hospital Medicine. 18(8). 670–676. 10 indexed citations
6.
Porter, Lauren C., et al.. (2022). “I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons. Health Services Research. 58(4). 865–872. 4 indexed citations
7.
Kattakuzhy, Sarah, Sun Jung Kang, Rachel Silk, et al.. (2022). Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. International Journal of Drug Policy. 111. 103906–103906. 3 indexed citations
8.
Carpenter, Joseph, Timothy P. Moran, Irene Kuo, et al.. (2021). 1362. Adding Insult to Injury: Association of Stigmatizing Language and Suboptimal Outcomes in People Who Inject Drugs. Open Forum Infectious Diseases. 8(Supplement_1). S767–S768. 1 indexed citations
9.
Silk, Rachel, Chloe Gross, David Sternberg, et al.. (2021). Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. Journal of Addiction Medicine. 16(1). 10–17. 8 indexed citations
10.
Weintraub, Eric, Chamindi Seneviratne, Jessica F. Magidson, et al.. (2021). Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder. JAMA Network Open. 4(8). e2118487–e2118487. 33 indexed citations
11.
Wilson, Eleanor, Jennifer Hoffmann, Benjamin Emmanuel, et al.. (2019). A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY). Journal of Hepatology. 71(3). 498–504. 13 indexed citations
12.
Abutaleb, Ameer, Sarah Kattakuzhy, Shyam Kottilil, Erin E. O’Connor, & Eleanor Wilson. (2018). Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns. Journal of NeuroVirology. 24(6). 670–678. 5 indexed citations
13.
Chairez, Cheryl, Mary McLaughlin, Rachel Silk, et al.. (2018). Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance. Clinical Infectious Diseases. 69(4). 571–576. 16 indexed citations
14.
Akoth, Elizabeth, Chloe Gross, Rachel Silk, Elana Rosenthal, & Sarah Kattakuzhy. (2017). A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting. Journal of the Association of Nurses in AIDS Care. 28(5). 680–684. 1 indexed citations
15.
Chairez, Cheryl, Elizabeth Akoth, Chloe Gross, et al.. (2017). No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV. The Journal of Infectious Diseases. 217(1). 47–50. 28 indexed citations
16.
Tang, Lydia, Zayani Sims, Amy Nelson, et al.. (2016). Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment. World Journal of Hepatology. 8(31). 1318–1318. 21 indexed citations
17.
Tang, Lydia, Honorine Ward, Sarah Kattakuzhy, Eleanor Wilson, & Shyam Kottilil. (2015). Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection. Expert Review of Gastroenterology & Hepatology. 10(1). 21–36. 7 indexed citations
18.
Wilson, Eleanor, Sarah Kattakuzhy, Sreetha Sidharthan, et al.. (2015). Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens. Clinical Infectious Diseases. 62(3). 280–288. 38 indexed citations
19.
Kattakuzhy, Sarah, et al.. (2014). Cytomegalovirus immune reconstitution inflammatory syndrome manifesting as acute appendicitis in an HIV-infected patient. BMC Infectious Diseases. 14(1). 313–313. 9 indexed citations
20.
Hadigan, Colleen & Sarah Kattakuzhy. (2014). Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus. Endocrinology and Metabolism Clinics of North America. 43(3). 685–696. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak Suri Breakdown of academic impact, for papers by Milan Khara Breakdown of academic impact, for papers by Philip Bruggmann Breakdown of academic impact, for papers by Marianne Jauncey Breakdown of academic impact, for papers by Katelyn J Cullen Breakdown of academic impact, for papers by Maryam Alavi Breakdown of academic impact, for papers by Alya Briceño Breakdown of academic impact, for papers by Håvard Midgard Breakdown of academic impact, for papers by Amira Mohsen Breakdown of academic impact, for papers by Eduardo Martínez
Rankless by CCL
2026